Discovery of vx-509 (decernotinib): a potent and selective janus kinase (jak) 3 inhibitor for the treatment of autoimmune diseases Deposition Author(s): Farmer, L. , Ledeboer, M.W. , Zuccola, H.J.
Date: 2015-03-17 Method: X-RAY DIFFRACTION Resolution: 1.78 Å Organism(s): Homo Sapiens Sequences Data: 4YTF_A